← Leaderboards
Nicholas F Kuhn
Sloan-Kettering Inst Can Research
$121,176
Attributed
$121,176
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $44.5K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$121,176 · 1
By mechanism
F31$121,176 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Omar Abdel-Wahab$18,758,829
- Prasad S. Adusumilli$7,809,681
- Eric L Smith$2,298,765
- Timothy An-Thy Chan$21,076,830
- Eirini Papapetrou$13,419,805
Others in their field
Other Emerging Leaders on “Experimental Study”
- John Hobbs · Suny At Stony Brook$42,194,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Christopher Bee · Suny At Stony Brook$41,239,084
- Lynn Briscoe · Leidos Biomedical Research, Inc.$24,024,342
- John Damon Chodera · Sloan-Kettering Inst Can Research$18,835,102
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
Research focus
Experimental StudyGenetic EngineeringEngineeringAdoptive TransferAntigen ReceptorsBiologyAntitumor ResponseAcute Lymphocytic LeukemiaCancer TherapyBaseBiologicalCd40 AntigensCd40 LigandCellsB-LymphocytesChimeric Antigen ReceptorB Lymphoid MalignancyChronic Lymphocytic LeukemiaClinically RelevantCytotoxicityDendritic CellsEffector CellCd19 GeneHematological Disease